US health-care agency officials recently defended their work to control and stop risks from the Zika virus and other mosquito-borne diseases before two House subcommittees. Officials from agencies including FDA, the National Institute of Allergy and Infectious Diseases (NIAID), and the Centers for Disease Control and Prevention argued for a steadier source of funding to support development of anti-mosquito-borne-disease diagnostics.
NIAID Director Anthony Fauci testified at the House Appropriations Labor and HHS Subcommittee hearing on May 17 and the House...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?